Prediction of nonresponsiveness to medium-dose intravenous immunoglobulin (1 g/kg) treatment: an effective and safe schedule of acute treatment for Kawasaki disease
Kyung Pil Moon (Moon KP), Beom Joon Kim (Kim BJ), Kyu Jin Lee (Lee KJ), Jin Hee Oh (Oh JH), Ji Whan Han (Han JW), Kyung Yil Lee (Lee KY), Soon Ju Lee (Lee SJ)
Clin Exp Pediatr. 2016;59(4):178-182.   Published online 2016 Apr 30     DOI: https://doi.org/10.3345/kjp.2016.59.4.178
Citations to this article as recorded by Crossref logo
Value of blood inflammatory markers for predicting intravenous immunoglobulin resistance in Kawasaki disease: A systematic review and meta-analysis
Chang Liu, Jiacheng Wu
Frontiers in Pediatrics.2022;[Epub]     CrossRef
Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study
Xiaoliang Liu, Lin Wang, Kaiyu Zhou, Shuran Shao, Yimin Hua, Mei Wu, Lei Liu, Chuan Wang
Pediatric Rheumatology.2021;[Epub]     CrossRef
Predictive value of Albumin-Bilirubin grade for intravenous immunoglobulin resistance in a large cohort of patients with Kawasaki disease: a prospective study
Yu Yan, Lina Qiao, Yimin Hua, Shuran Shao, Nanjun Zhang, Mei Wu, Lei Liu, Kaiyu Zhou, Xiaoliang Liu, Chuan Wang
Pediatric Rheumatology.2021;[Epub]     CrossRef
Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease
Bin Tang, Hang Hong Lo, Cheng Lei, Ka In U, Wen-Luan Wendy Hsiao, Xiaoling Guo, Jun Bai, Vincent Kam-Wai Wong, Betty Yuen-Kwan Law
Phytomedicine.2020; 70: 153208.     CrossRef